Equifax's (EFX) "Buy" Rating Reaffirmed at Needham & Company LLC

Equifax (NYSE:EFX - Get Free Report)'s stock had its "buy" rating reissued by analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $295.00 price objective on the credit services provider's stock. Needham & Company LLC's target price indicates a potential upside of 15.91% from the company's previous close. Needham & Company LLC also issued estimates for Equifax's Q3 2025 earnings at $1.99 EPS, Q4 2025 earnings at $2.04 EPS and FY2026 earnings at $8.35 EPS.

A number of other research analysts have also recently issued reports on the stock. William Blair restated an "outperform" rating on shares of Equifax in a report on Friday, February 7th. Argus cut shares of Equifax from a "buy" rating to a "hold" rating in a research report on Tuesday, February 11th. Jefferies Financial Group cut their target price on Equifax from $340.00 to $300.00 and set a "buy" rating on the stock in a report on Wednesday, January 15th. Oppenheimer dropped their price objective on shares of Equifax from $286.00 to $279.00 and set an "outperform" rating on the stock in a report on Friday, February 7th. Finally, Barclays reaffirmed an "equal weight" rating and set a $260.00 target price (down previously from $325.00) on shares of Equifax in a research report on Friday, April 4th. Five analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Equifax has an average rating of "Moderate Buy" and an average price target of $292.00.

Equifax Trading Down 0.8 %

NYSE:EFX traded down $1.97 on Wednesday, hitting $254.52. 308,356 shares of the stock were exchanged, compared to its average volume of 962,881. The company has a current ratio of 0.75, a quick ratio of 0.88 and a debt-to-equity ratio of 0.90. Equifax has a fifty-two week low of $199.98 and a fifty-two week high of $309.63. The stock has a fifty day moving average of $236.34 and a 200-day moving average of $253.52. The stock has a market cap of $31.61 billion, a PE ratio of 52.77, a PEG ratio of 2.79 and a beta of 1.65.

Equifax (NYSE:EFX - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The credit services provider reported $1.53 EPS for the quarter, beating the consensus estimate of $1.45 by $0.08. The firm had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.41 billion. Equifax had a return on equity of 19.13% and a net margin of 10.63%. As a group, equities analysts expect that Equifax will post 7.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Equifax

A number of institutional investors have recently modified their holdings of the company. McClarren Financial Advisors Inc. bought a new stake in shares of Equifax during the fourth quarter worth $25,000. True Wealth Design LLC raised its position in Equifax by 1,920.0% in the 4th quarter. True Wealth Design LLC now owns 101 shares of the credit services provider's stock valued at $26,000 after buying an additional 96 shares during the last quarter. Ameriflex Group Inc. bought a new position in shares of Equifax in the 4th quarter valued at about $28,000. Colonial Trust Co SC increased its holdings in Equifax by 505.0% during the fourth quarter. Colonial Trust Co SC now owns 121 shares of the credit services provider's stock worth $31,000 after buying an additional 101 shares during the last quarter. Finally, Central Pacific Bank Trust Division acquired a new position in shares of Equifax during the 4th quarter worth approximately $35,000. Institutional investors own 96.20% of the company's stock.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.